Guinv Hu

479 total citations
24 papers, 383 citations indexed

About

Guinv Hu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guinv Hu has authored 24 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guinv Hu's work include Cellular Mechanics and Interactions (3 papers), RNA modifications and cancer (3 papers) and HER2/EGFR in Cancer Research (3 papers). Guinv Hu is often cited by papers focused on Cellular Mechanics and Interactions (3 papers), RNA modifications and cancer (3 papers) and HER2/EGFR in Cancer Research (3 papers). Guinv Hu collaborates with scholars based in China, Taiwan and United States. Guinv Hu's co-authors include Chih‐Hsin Tang, Chaoqun Wang, Bifei Huang, Xiaoni Li, Chen‐Ming Su, Liting Lv, Yan Wang, Lulu Jin, Qian Wang and Huey-En Tzeng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Guinv Hu

21 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guinv Hu China	12	237	151	104	48	46	24	383
Sampa Ghose India	12	185 0.8×	99 0.7×	67 0.6×	52 1.1×	40 0.9×	20	344
Bifei Huang China	12	185 0.8×	97 0.6×	91 0.9×	54 1.1×	37 0.8×	30	333
Dongyi Wan China	10	326 1.4×	146 1.0×	153 1.5×	44 0.9×	50 1.1×	16	481
Diana Becker Germany	14	237 1.0×	127 0.8×	132 1.3×	64 1.3×	59 1.3×	22	426
Katja Helenius Finland	5	276 1.2×	89 0.6×	119 1.1×	48 1.0×	23 0.5×	6	383
Junhao Mu China	14	333 1.4×	119 0.8×	71 0.7×	67 1.4×	27 0.6×	23	442
Julian Musa Germany	8	334 1.4×	136 0.9×	113 1.1×	108 2.3×	42 0.9×	18	500
Shaolin Nie China	9	261 1.1×	234 1.5×	63 0.6×	26 0.5×	26 0.6×	10	368
Caifeng Yue China	9	305 1.3×	150 1.0×	113 1.1×	51 1.1×	84 1.8×	20	481
Dejun Wu China	12	323 1.4×	213 1.4×	98 0.9×	90 1.9×	40 0.9×	19	467

Countries citing papers authored by Guinv Hu

Since Specialization

Citations

This map shows the geographic impact of Guinv Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guinv Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guinv Hu more than expected).

Fields of papers citing papers by Guinv Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guinv Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guinv Hu. The network helps show where Guinv Hu may publish in the future.

Co-authorship network of co-authors of Guinv Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Guinv Hu. A scholar is included among the top collaborators of Guinv Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guinv Hu. Guinv Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wenhui, Jiming Chen, Shibo Wang, et al.. (2025). MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1. Cell Reports Medicine. 6(2). 101922–101922. 5 indexed citations

Lü, Ping, Xiang Shi Tan, Guinv Hu, et al.. (2024). Guideline concordance of recurrence risk assessment for early breast cancer in a county-level setting in China.. Journal of Clinical Oncology. 42(16_suppl). e23263–e23263.

Wang, Jiang, et al.. (2024). Clinicopathological characteristics and prognostic significance of casting-type calcifications in patients with invasive breast cancer presenting with microcalcification. Scientific Reports. 14(1). 13351–13351. 3 indexed citations

Jin, Lulu, H. Lu, Yan Wang, et al.. (2023). Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer. Molecular and Cellular Biochemistry. 479(11). 3037–3047. 5 indexed citations

Chen, Dalei, et al.. (2022). Theaflavin Attenuates TBHP-Induced Endothelial Cells Oxidative Stress by Activating PI3K/AKT/Nrf2 and Accelerates Wound Healing in Rats. Frontiers in Bioengineering and Biotechnology. 10. 830574–830574. 14 indexed citations

Wang, Chaoqun, Chih‐Hsin Tang, Yan Wang, et al.. (2022). Upregulated WTAP expression appears to both promote breast cancer growth and inhibit lymph node metastasis. Scientific Reports. 12(1). 1023–1023. 17 indexed citations

Hu, Guinv, Yan Wang, Chih‐Hsin Tang, et al.. (2022). The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms. Scientific Reports. 12(1). 14522–14522.

Yang, Lihua, et al.. (2021). Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer. Clinical & Translational Oncology. 23(11). 2220–2236. 5 indexed citations

Wang, Yan, Qian Wang, Chih‐Hsin Tang, et al.. (2021). p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status. Medicine. 100(10). e25124–e25124. 8 indexed citations

10.

Hu, Guinv, et al.. (2020). A new clinical prognostic nomogram for liver cancer based on immune score. PLoS ONE. 15(7). e0236622–e0236622. 7 indexed citations

11.

Wang, Yan, Bifei Huang, Guinv Hu, et al.. (2020). Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification. BioMed Research International. 2020(1). 8823270–8823270. 13 indexed citations

12.

Tang, Chih‐Hsin, Huey-En Tzeng, Lulu Jin, et al.. (2020). Impacts of RETN genetic polymorphism on breast cancer development. Journal of Cancer. 11(10). 2769–2777. 15 indexed citations

13.

Lv, Liting, et al.. (2020). Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma. Frontiers in Genetics. 11. 294–294. 15 indexed citations

14.

Hu, Guinv, et al.. (2018). Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer. International Journal of Medical Sciences. 15(11). 1179–1186. 13 indexed citations

15.

Huang, Bifei, Huey-En Tzeng, Po‐Chun Chen, et al.. (2018). HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer. International Journal of Medical Sciences. 15(6). 580–586. 29 indexed citations

16.

Wang, Chaoqun, Chih‐Hsin Tang, Yan Wang, et al.. (2017). FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer. Scientific Reports. 7(1). 15887–15887. 43 indexed citations

17.

Wang, Chaoqun, Yang Li, Bifei Huang, et al.. (2017). EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Scientific Reports. 7(1). 15654–15654. 41 indexed citations

18.

Wang, Zeng, et al.. (2016). A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Molecular and Clinical Oncology. 5(2). 395–399. 10 indexed citations

19.

Lu, Xingang, et al.. (2015). TCF7L2 gene polymorphisms and susceptibility to breast cancer: a meta-analysis. Genetics and Molecular Research. 14(1). 2860–2867. 11 indexed citations

20.

Lin, Changwei, Guinv Hu, Yirui Guo, et al.. (2014). TAp63 suppress metastasis via miR-133b in colon cancer cells. British Journal of Cancer. 110(9). 2310–2320. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact